Rigetti Beats Q1 Estimates, but Fundamentals Still Don't Support Valuation

What happened

Rigetti Computing reported Q1 revenue of $4.4M, up 199% YoY and above analyst expectations of $4.09M, driven by higher sales of Novera 9-qubit systems. However, operating loss remained deep at $26.0M, and the beat does not change the underlying revenue lumpiness and low backlog visibility. The company guided that revenue timing will 'vary significantly,' and customer concentration remains high with Customer A at 54% of sales. The $569M cash pile provides a buffer, but the WAIT-rated thesis hinges on whether remaining performance obligations (RPO) can grow from the current ~$2.8M level and whether large orders like the C-DAC 108-qubit system deploy on schedule in 2H26. Until bookings convert to recognized revenue in a repeatable fashion, the stock remains a high-beta quantum option driven by headlines rather than fundamentals.

Implication

The revenue beat provides a short-term catalyst, but with operating losses still ~6x revenue, the company is pricing in significant future growth that requires repeat orders, not one-off shipments. Key checkpoints remain the conversion of 1H26 Novera purchase orders (~$5.7M), RPO growth above ~$2.8M, and the C-DAC deployment timeline – none of which are derisked by this earnings beat. The $569M cash hoard reduces near-term funding risk, but dilution overhang from the $350M ATM and 33.7M equity plan shares caps upside for patient investors. Given the WAIT rating with a $16 attractive entry versus current ~$20.50, investors should wait for more concrete evidence of commercialization before adding or initiating positions. A re-rating to the bull case of $30 requires RPO to reach $20M–$30M and per-quarter cash burn to stay below $20M; the Q1 report does not move the needle on those metrics.

Thesis delta

The Q1 revenue beat is mildly supportive of the commercialization trajectory, but does not alter the structurally lumpy nature of the business or the need for RPO expansion to reduce volatility. The thesis remains anchored to the 6-12 month conversion of purchase orders and backlog growth; near-term price action may overshoot on sentiment, but fundamental justification for a re-rating is still absent.